Fairfax Media network navigation

  • Home
  • Shares
  • Share details

SCIGEN LIMITED (SIE)


Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today » it's FREE! Already a member? Login now!


General Information
Company Name: SciGen Limited
Stock Code: SIE
Website: www.scigenltd.com
GICS Sub-Industry: Pharmaceuticals
Market Cap ($M): 2
Equiv. Shares (M): 52

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
$ 0.038 $ 0.000 $ 0.000 $ 0.000 $ 0.038 0 0%

Company Overview

Business Description:
SciGen Limited (SIE) is a biopharmaceutical company engaged in co-developing and marketing genetically engineered biopharmaceutical products for human healthcare. SIE focuses in the areas of gastroenterology, endocrinology and immunology. SIE’s portfolio consists of biosimilar products such as rhuman growth hormone, rhuman insulin and rhuman Granulocyte Colony Stimulating Factor (GCSF). SIE is a Singapore-based company, with representatives in Asia Pacific region.

Financial Summary
Year to Dec NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2012  A 0.1 0.0 -- 5.8 0.0 0.0 --
2011  A -5.4 -1.0 -- 0.0 0.0 0.0 --
2010  A -9.6 -1.7 -- 0.0 0.0 0.0 --
Source: Aspect actuals / Thomson IBES estimates

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2010 A 2011 F 2012 F 2010 A 2011 F 2012 F 2010 A 2011 F 2012 F
Acrux Limited (ACR) $636 M -0.8713 0.9752 0.7400 86.0360 43.5576 25.0328 0.0209 0.0198 0.0458
Pharmaxis (PXS) $45 M -- -- -- -- -- -- 0.0000 -- --
SciGen (SIE) $2 M -- -- -- 4.6914 -- -- 0.0000 -- --

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
SIE -- 4.69 -0.36 -- 1.20
Market 1.13 13.2 0.92 2.50 2.58
Sector 0.65 21.3 2.39 0.55 6.49

Directors
Name Position Start Date
Mr Slawomir Ziegert Chief Executive Officer,Executive Director,Executive Chairman 01 December 2009
Ms Jenny Low Company Secretary,Vice President   
Mr Adam Polonek Executive Director,Chief Financial Officer 26 June 2008
Mr Marcin Dukaczewski Non-Executive Director 26 December 2008
Mr Kenneth Gross Non-Executive Director (other) 03 July 2000
Mr Adam Wilczega Non-Executive Director (other) 11 April 2005
Joanna Szymanska-Bulska Non-Executive Director (other) 26 June 2008
Mr Amol Jashvant Shah Non-Executive Director (other) 01 December 2009
Mr Mateusz Patryk Kosecki Non-Executive Director (other) 01 December 2009

Management
Name Position
Li Minyi Accounts Executive
Lai Leng Wong Company Secretary
Liza Domingo Country Manager - Philippines
Hedy Ong Finance and Logistics Manager
Yvonne Lim Group Financial Controller
Marcus Poh Regional Marketing Manager

Substantial Shareholders
Holding Name
527,786,735 (95.57%) Bioton S.A.

Calendar of Events
Date Event
27 February 2014 Report (Prelim)
28 August 2013 Report (Interim)
03 June 2013 Report (Annual)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.

Advertisement

Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Investing in Property through Super

An educational booklet on running your own superannuation fund and investing in property.

More details...

News

Plummeting dollar, budget steal limelight

The Age 18/05/2013 | The sharemarket lost ground this week, slipping 0.6 per cent, but the dollar stole the headlines after dropping like an anvil.

Break-up could breathe new life into News

The Age 18/05/2013 | Analysts say the split into two divisions may lead to a re-rating of the embattled publishing business, writes Colin Kruger.

Wesfarmers shares fall short of their Target

The Age 18/05/2013 | Wesfarmers shares suffered their biggest fall in almost two years after sharply lowering Target's earnings forecast.

China the new competitor in Australia's online sales

The Age 18/05/2013 | As Australia's major retailers increase their online sales channels, pouring millions into their websites, they could face new competition from China's booming e-commerce industry.

China roars along e-tailing superhighway

The Age 18/05/2013 | Mass consumption is coming of age in the internet era, write Richard Cooper and Richard Dobbs.

Delayed return to surplus no worry - what causes it is

The Age 18/05/2013 | Most of those who take a political approach to the budget assume that if it's in deficit, the way you get it back to surplus is to cut government spending or, if you're a really bad person, increase taxes. They forget it's the budget itself that's supposed to do the heavy lifting.

More...

Sponsored Links
Feedback Form